These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 1760884

  • 1. Phosphatase isoenzymes as bone metastasis markers in prostatic carcinoma.
    Desoize B, Amico S, Larbre H, Coninx P, Jardillier JC.
    Clin Biochem; 1991 Oct; 24(5):443-6. PubMed ID: 1760884
    [Abstract] [Full Text] [Related]

  • 2. Comparison of phosphatase isoenzymes PAP and PSA with bone scan in patients with prostate carcinoma.
    Amico S, Liehn JC, Desoize B, Larbre H, Deltour G, Valeyre J.
    Clin Nucl Med; 1991 Sep; 16(9):643-8. PubMed ID: 1718651
    [Abstract] [Full Text] [Related]

  • 3. Prediction of bone metastases by combination of tartrate-resistant acid phosphatase, alkaline phosphatase and prostate specific antigen in patients with prostate cancer.
    Ozu C, Nakashima J, Horiguchi Y, Oya M, Ohigashi T, Murai M.
    Int J Urol; 2008 May; 15(5):419-22. PubMed ID: 18452459
    [Abstract] [Full Text] [Related]

  • 4. [Evaluation of two serum isoenzyme phosphatases as bone metastasis markers].
    Desoize B, Pourny C, Amico S, Larbre H, Jardillier JC.
    Bull Cancer; 1990 May; 77(12):1211-21. PubMed ID: 2081281
    [Abstract] [Full Text] [Related]

  • 5. Relationship between prostate-specific antigen, clinical stage, and degree of bone metastasis in patients with prostate cancer: comparison with prostatic acid phosphatase and alkaline phosphatase.
    Akimoto S, Furuya Y, Akakura K, Shimazaki J, Ito H.
    Int J Urol; 1997 Nov; 4(6):572-5. PubMed ID: 9477186
    [Abstract] [Full Text] [Related]

  • 6. Isoenzymes of alkaline and acid phosphatases as bones metastasis marker in breast cancer patients.
    Desoize B, Veiler V, Pourny C, Comoe L, Jardillier JC.
    Anticancer Res; 1989 Nov; 9(4):1105-9. PubMed ID: 2817792
    [Abstract] [Full Text] [Related]

  • 7. Serum tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of skeletal changes in prostate cancer.
    Salminen E, Ala-Houhala M, Korpela J, Varpula M, Tiitinen SL, Halleen JM, Väänänen HK.
    Acta Oncol; 2005 Nov; 44(7):742-7. PubMed ID: 16227166
    [Abstract] [Full Text] [Related]

  • 8. Plasma acid and alkaline phosphatase in patients with breast cancer.
    Nguyen M, Bonneterre J, Hecquet B, Desoize B, Demaille A.
    Anticancer Res; 1991 Nov; 11(2):831-3. PubMed ID: 2064338
    [Abstract] [Full Text] [Related]

  • 9. Implications of serum bone turnover markers in prostate cancer patients with bone metastasis.
    Kamiya N, Suzuki H, Yano M, Endo T, Takano M, Komaru A, Kawamura K, Sekita N, Imamoto T, Ichikawa T.
    Urology; 2010 Jun; 75(6):1446-51. PubMed ID: 20206975
    [Abstract] [Full Text] [Related]

  • 10. The significance of serum alkaline phosphatase bone isoenzyme in prostatic carcinoma with bony metastasis.
    Chen SS, Chen KK, Lin AT, Chang YH, Wu HH, Hsu TH, Chang LS.
    Br J Urol; 1997 Feb; 79(2):217-20. PubMed ID: 9052473
    [Abstract] [Full Text] [Related]

  • 11. Survival markers related to bone metastases in prostate cancer.
    Salminen EK, Kallioinen MJ, Ala-Houhala MA, Vihinen PP, Tiitinen SL, Varpula M, Vahlberg TJ.
    Anticancer Res; 2006 Feb; 26(6C):4879-84. PubMed ID: 17214355
    [Abstract] [Full Text] [Related]

  • 12. The use of serum isoenzymes of alkaline and acid phosphatase as possible quantitative markers of tumor load in prostate cancer.
    Killian CS, Vargas FP, Pontes EJ, Beckley S, Slack NH, Murphy GP, Chu TM.
    Prostate; 1981 Feb; 2(2):187-206. PubMed ID: 7301655
    [Abstract] [Full Text] [Related]

  • 13. Bone scintigraphy and serum phosphatases in the detection and follow-up of bone metastases in prostatic cancer.
    Liewendahl K, Alfthan O, Ikonen T, Ruutu M, Rannikko S.
    Scand J Urol Nephrol; 1984 Feb; 18(3):181-5. PubMed ID: 6494827
    [Abstract] [Full Text] [Related]

  • 14. Serum tartrate resistant acid phosphatase as a potential marker of bone metastasis from breast cancer.
    Wada N, Ishii S, Ikeda T, Enomoto K, Kitajima M.
    Anticancer Res; 1999 Feb; 19(5C):4515-21. PubMed ID: 10650803
    [Abstract] [Full Text] [Related]

  • 15. [Measurement of skeletal alkaline phosphatase in prostatic carcinoma. Preliminary report].
    Casetta G, Gamba P, Piana P, Pecchio F, Tizzani A.
    Minerva Urol Nefrol; 1995 Mar; 47(1):9-12. PubMed ID: 7570264
    [Abstract] [Full Text] [Related]

  • 16. Clinical significance of serum BAP, TRACP 5b and ICTP as bone metabolic markers for bone metastasis screening in lung cancer patients.
    Tang C, Liu Y, Qin H, Li X, Guo W, Li J, Wang W, Qu L, Hu H, Xu C, Zheng L, Huang Y, Liu B, Gao H, Halleen JM, Liu X.
    Clin Chim Acta; 2013 Nov 15; 426():102-7. PubMed ID: 24055775
    [Abstract] [Full Text] [Related]

  • 17. Advanced prostate cancer follow-up with prostate-specific antigen, prostatic acid phosphatase, osteocalcin and bone isoenzyme of alkaline phosphatase.
    Curatolo C, Ludovico GM, Correale M, Pagliarulo A, Abbate I, Cirrillo Marucco E, Barletta A.
    Eur Urol; 1992 Nov 15; 21 Suppl 1():105-7. PubMed ID: 1385127
    [Abstract] [Full Text] [Related]

  • 18. [Relationship of serum prostate-specific antigen and alkaline phosphatase levels with bone metastases in patients with prostate cancer].
    Wang ZL, Wang XF.
    Zhonghua Nan Ke Xue; 2005 Nov 15; 11(11):825-7. PubMed ID: 16333960
    [Abstract] [Full Text] [Related]

  • 19. Tartrate-resistant acid phosphatase 5b activity is a useful bone marker for monitoring bone metastases in breast cancer patients after treatment.
    Chung YC, Ku CH, Chao TY, Yu JC, Chen MM, Lee SH.
    Cancer Epidemiol Biomarkers Prev; 2006 Mar 15; 15(3):424-8. PubMed ID: 16537696
    [Abstract] [Full Text] [Related]

  • 20. Comparison of markers of bone formation and resorption in prostate cancer patients to predict bone metastasis.
    Akimoto S, Furuya Y, Akakura K, Ito H.
    Endocr J; 1998 Feb 15; 45(1):97-104. PubMed ID: 9625452
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.